Ralph Corey
Overview
Explore the profile of Ralph Corey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mittal S, Wilkoff B, Kennergren C, Poole J, Corey R, Bracke F, et al.
Heart Rhythm
. 2020 Feb;
17(7):1115-1122.
PMID: 32087357
Background: The World-wide Randomized Antibiotic Envelope Infection Prevention trial reported a 40% reduction in major cardiac implantable electronic device (CIED) infections within 12 months of the procedure with the use...
2.
Corey R, Moran G, Goering R, Bensaci M, Sandison T, De Anda C, et al.
Diagn Microbiol Infect Dis
. 2019 Apr;
94(3):277-286.
PMID: 30940414
We evaluated the microbiological efficacy of tedizolid compared with that of linezolid against common and emerging pathogens using pooled data from 2 phase 3 trials (NCT01170221 and NCT01421511) in patients...
3.
Tarakji K, Mittal S, Kennergren C, Corey R, Poole J, Schloss E, et al.
N Engl J Med
. 2019 Mar;
380(20):1895-1905.
PMID: 30883056
Background: Infections after placement of cardiac implantable electronic devices (CIEDs) are associated with substantial morbidity and mortality. There is limited evidence on prophylactic strategies, other than the use of preoperative...
4.
Lodise T, Corey R, Hooper D, Cammarata S
Open Forum Infect Dis
. 2018 Oct;
5(10):ofy220.
PMID: 30349845
Background: Fluoroquinolones have been widely used for a variety of Gram-positive and Gram-negative infections, and by 2002 they had become the most commonly prescribed class of antibiotics for adults in...
5.
Nathwani D, Corey R, Das A, Sandison T, De Anda C, Prokocimer P
Clin Infect Dis
. 2016 Dec;
64(2):214-217.
PMID: 28003218
Clinical Trials Registration: NCT01170221; NCT01421511.
6.
Tarakji K, Mittal S, Kennergren C, Corey R, Poole J, Stromberg K, et al.
Am Heart J
. 2016 Sep;
180:12-21.
PMID: 27659878
Background: Cardiac implantable electronic device (CIED) infection is a major complication that is associated with significant morbidity and mortality. The aim of this study is to determine whether Medtronic TYRX...
7.
Corey R, Naderer O, ORiordan W, Dumont E, Jones L, Kurtinecz M, et al.
Antimicrob Agents Chemother
. 2014 Aug;
58(11):6518-27.
PMID: 25136015
GSK1322322 represents a new class of antibiotics that targets an essential bacterial enzyme required for protein maturation, peptide deformylase. This multicenter, randomized, phase IIa study compared the safety, tolerability, and...
8.
Chow S, Corey R, Lin M
J Biopharm Stat
. 2012 Jun;
22(4):853-67.
PMID: 22651119
In clinical trials, an independent data monitoring committee (DMC) is often established to perform both ongoing safety data monitoring and interim efficacy analysis. These evaluations are performed in a blinded...
9.
Chow S, Corey R
Orphanet J Rare Dis
. 2011 Dec;
6:79.
PMID: 22129361
In recent years, the use of adaptive design methods in pharmaceutical/clinical research and development has become popular due to its flexibility and efficiency for identifying potential signals of clinical benefit...
10.
Kanafani Z, Boucher H, Fowler V, Cabell C, Hoen B, Miro J, et al.
Enferm Infecc Microbiol Clin
. 2010 Mar;
28(8):498-503.
PMID: 20188444
Introduction: In a recent randomized trial of Staphylococcus aureus bacteremia and native valve endocarditis, daptomycin was found not inferior to standard therapy. We summarized findings in the subgroup of patients...